Journal article
NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.
- Abstract:
-
BACKGROUND: Both oxaliplatin/capecitabine-based chemoradiation (OXCAP-RT) and carboplatin-paclitaxel based radiation (CarPac-RT) are active regimens in oesophageal adenocarcinoma, but no randomised study has compared their efficacy and toxicity. This randomised phase II "pick a winner" trial will identify the optimum regimen to take forward to a future phase III trial against neo-adjuvant chemotherapy, the current standard in the UK. METHODS/DESIGN: Patients with resectable adenocarcinoma of ...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 929.8KB)
-
- Publisher copy:
- 10.1186/s12885-015-1062-y
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Funding
+ National Institute for Health Research Oxford Biomedical Research Centre
More from this funder
Funding agency for:
Mukherjee, S
+ CRUK Experimental Cancer Medicines Centre, Oxford
More from this funder
Funding agency for:
Mukherjee, S
+ National Institute for Health Research Oxford Biomedical Research Centre
More from this funder
Funding agency for:
Sharma, R
+ CRUK Experimental Cancer Medicines Centre, Oxford
More from this funder
Funding agency for:
Sharma, R
Expand funders...
Bibliographic Details
- Publisher:
- BioMed Central Publisher's website
- Journal:
- BMC cancer Journal website
- Volume:
- 15
- Issue:
- 1
- Pages:
- 1062
- Publication date:
- 2015-12-01
- DOI:
- EISSN:
-
1471-2407
- ISSN:
-
1471-2407
- Source identifiers:
-
510248
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:510248
- UUID:
-
uuid:68bd0c47-13aa-41a0-8cc0-56581a667247
- Local pid:
- pubs:510248
- Deposit date:
- 2015-11-20
Terms of use
- Copyright holder:
- Mukherjee et al
- Copyright date:
- 2015
- Notes:
-
Copyright © 2015 Mukherjee et al.; licensee BioMed Central.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record